Anbio Biotechnology Class A Ordinary Shares Stock Forecast

Sell candidate since Jun 03, 2026 Loss -66.71%

The Anbio Biotechnology Class A Ordinary stock price fell by -1.15% on the last day (Friday, 17th Jul 2026) from $9.60 to $9.49. During the last trading day the stock fluctuated 12.19% from a day low at $8.78 to a day high of $9.85. The price has fallen in 8 of the last 10 days and is down by -25.28% for this period. Volume has increased on the last day by 24 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 52 thousand shares were bought and sold for approximately $490.27 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $8.37 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -50.70% during the next 3 months and, with a 90% probability hold a price between $4.13 and $10.90 at the end of this 3-month period.

NNNN Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 15, 2026, and so far it has risen 4.06%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Anbio Biotechnology Class A Ordinary stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $9.75 and $16.88. A break-up above any of these levels will issue buy signals. Anbio Biotechnology Class A Ordinary gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Anbio Biotechnology Class A Ordinary stock

Anbio Biotechnology Class A Ordinary finds support from accumulated volume at $9.39 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.07 between high and low, or 12.19%. For the last week, the stock has had daily average volatility of 14.00%.

Anbio Biotechnology Class A Ordinary is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NNNN) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Anbio Biotechnology Class A Ordinary Shares to open at $9.37, and during the day (based on 14 day Average True Range), to move between $8.48 and $10.50, which gives a possible trading interval of +/-$2.02 (+/-23.77%) up or down from last closing price. If Anbio Biotechnology Class A Ordinary Shares takes out the full calculated possible swing range there will be an estimated 23.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $9.39 (1.05%) than the resistance at $9.97 (5.06%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Anbio Biotechnology Class A Ordinary Shares stock A Buy?

Anbio Biotechnology Class A Ordinary holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.397 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $9.37 ( 1.23%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk